Ching‐Feng Chiu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Global Cancer Incidence and Screening
Papers in
-
- RNA modifications and cancer 6
- Gut microbiota and health 3
- Epigenetics and DNA Methylation 3
-
- Cancer, Hypoxia, and Metabolism 7
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
- Co-authors
- Hari H. Dayal (2 shared papers)Raoul J. Burchette (1 shared paper)Linda Hyder Ferry (1 shared paper)Donn Muhleman (1 shared paper)Shu‐Mei Liang (4 shared papers)Yen‐Hao Su (13 shared papers)Chih‐Hsiang Leng (1 shared paper)Shao-Wen Hung (9 shared papers)
- Journals
- Annals of Surgical Oncology (4 papers)Cancer Research (2 papers)Scientific Reports (2 papers)Aging (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- TaiwanUnited StatesThailand
In The Last Decade
Ching‐Feng Chiu
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 257
- Oncology 272
- Molecular Biology 588
- Physiology 136
- Cellular and Molecular Neuroscience 98
Countries citing papers authored by Ching‐Feng Chiu
This map shows the geographic impact of Ching‐Feng Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Feng Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Feng Chiu more than expected).
Fields of papers citing papers by Ching‐Feng Chiu
This network shows the impact of papers produced by Ching‐Feng Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Feng Chiu. The network helps show where Ching‐Feng Chiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching‐Feng Chiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 230 | |
| 2 | 1982 | 192 | |
| 3 | 2008 | 104 | |
| 4 | 2016 | 76 | |
| 5 | 2017 | 62 | |
| 6 | 1982 | 41 | |
| 7 | 2019 | 30 | |
| 8 | 2015 | 29 | |
| 9 | 2014 | 28 | |
| 10 | 2021 | 28 | |
| 11 | 2022 | 27 | |
| 12 | 2014 | 26 | |
| 13 | 2014 | 25 | |
| 14 | 2014 | 25 | |
| 15 | 2014 | 23 | |
| 16 | 2020 | 22 | |
| 17 | 2022 | 22 | |
| 18 | 2011 | 20 | |
| 19 | 2021 | 18 | |
| 20 | 2020 | 18 |
About Ching‐Feng Chiu
Ching‐Feng Chiu is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pharmacology, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Gut microbiota and health (3 papers), Epigenetics and DNA Methylation (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (257 citations), Oncology (272 citations), Molecular Biology (588 citations), Physiology (136 citations) and Cellular and Molecular Neuroscience (98 citations). Ching‐Feng Chiu has collaborated with scholars based in Taiwan, United States and Thailand. Frequent co-authors include Hari H. Dayal, Raoul J. Burchette, Linda Hyder Ferry, Donn Muhleman, Shu‐Mei Liang, Yen‐Hao Su, Chih‐Hsiang Leng, Shao-Wen Hung, Su‐Ming Hu and Ting‐Fang Wang. Their work appears in journals such as Annals of Surgical Oncology, Cancer Research, Scientific Reports, Aging and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.